l General Information |
Product Name | Ozagrel sodium |
General description | Ozagrel sodium is a selective thromboxane A(2) (TXA(2)) synthetase inhibitor. |
Synonym | sodium; (E)-3-[4-(imidazol-1-ylmethyl)phenyl]prop-2-enoate |
Purity | ≥98%(HPLC) | CAS Number | 189224-26-8 |
Formula | C13H11N2NaO2 | Molecular Weight | 250.233 |
Suitability | BioReagent, suitable for cell culture, etc. |
l Physical and Chemical Information |
Appearance | White or Off-white solid |
Solubility(25℃) | DMSO | ~1mg/mL |
Ethanol | Insoluble |
Water | ≥40mg/mL |
l Biological Information |
Biochem/Physiol Actions | Ozagrel is a selective thromboxane A(2) (TXA(2)) synthetase inhibitor with IC50 of 11 nM for rabbit platelet, used for the improvement of postoperative cerebrovascular contraction and accompanying cerebral ischaemia. |
Application | 1. Enzyme Inhibitors 2. Fibrinolytic Agents 3. Histamine Antagonists |
l Packaging & Storage |
Packaging | 1g |
Storage temp. | 0-5℃ |
l Precautions and Disclaimer |
This product is for R&D use only, not for drug, household, or other uses. |
l References |
1. http://www.drugbank.ca 2. https://ncit.nci.nih.gov 3. https://www.ncbi.nlm.nih.gov |
